Abstract
The anterior cingulate cortex (ACC) is one of several brain regions that are abnormal in schizophrenia (SZ). Here we compared markers of synapse and mitochondrial function using western blots of postmortem ACC in: 1) normal controls (NCs, n=13) vs subjects with SZ (n=25); NC, treatment-resistant SZ, and treatment-responsive SZ; and 3) NC and SZ treated with typical or atypical antipsychotic drugs (APDs). Protein levels of synaptophysin, mitofusin-2, vGLUT1, and calcineurin did not differ between the NC and SZ group as a whole, or the NCs vs the SZ group divided by treatment response or type of APDs. In several cases, the levels of vGLUT1 were minuscule or absent. The proportion of NCs lacking vGLUT1 was significantly less than that of the SZ groups. There were several positive correlations across all subjects between: 1) synaptophysin and vGLUT1; 2) synaptophysin and calcineurin; 3) synaptophysin and mitofusin; and 4) calcineurin and mitofusin. Synaptophysin and calcineurin were positively correlated in responders, and this correlation was significantly stronger than that in treatment-resistant SZ subjects or in NCs. Synaptophysin and calcineurin were positively correlated in SZ patients on atypical APDs; this correlation was significantly stronger than that in SZ patients on typical APDs or in NCs. Mitofusin-2 and calcineurin were positively correlated in SZ patients on atypical APDs and in NCs; this correlation was stronger in SZ patients on atypical rather than typical APDs or in NCs. The correlation between these proteins, which have roles in synaptic vesicle cycling, glutamate transmission, mitochondrial fusion, and calcium buffering, is complex and was differentially regulated among the groups.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Altamura AC, Bassetti R, Cattaneo E, Vismara S (2005). Some biological correlates of drug resistance in schizophrenia: a multidimensional approach. World J Biol Psychiatry 6 (Suppl 2): 23–30.
Anglin RE, Mazurek MF, Tarnopolsky MA, Rosebush PI (2012). The mitochondrial genome and psychiatric illness. Am J Med Genet B Neuropsychiatr Genet 159B: 749–759.
Bach D, Pich S, Soriano FX, Vega N, Baumgartner B, Oriola J et al (2003). Mitofusin-2 determines mitochondrial network architecture and mitochondrial metabolism. A novel regulatory mechanism altered in obesity. J Biol Chem 278: 17190–17197.
Baumgärtel K, Mansuy IM (2012). Neural functions of calcineurin in synaptic plasticity and memory. Learn Mem 19: 375–384.
Bellocchio EE, Reimer RJ, Fremeau RT Jr, Edwards RH (2000). Uptake of glutamate into synaptic vesicles by an inorganic phosphate transporter. Science 289: 957–960.
Calhoun ME, Jucker M, Martin LJ, Thinakaran G, Price DL, Mouton PR (1996). Comparative evaluation of synaptophysin-based methods for quantification of synapses. J Neurocytol 12: 821–828.
Clayton EL, Anggono V, Smillie KJ, Chau N, Robinson PJ, Cousin MA (2009). The phospho-dependent dynamin-syndapin interaction triggers activity-dependent bulk endocytosis of synaptic vesicles. J Neurosci 29: 7706–7717.
Conley RR, Kelly DL (2001). Management of treatment resistance in schizophrenia. Biol Psychiatry 50: 898–911.
Daly C, Sugimori M, Moreira JE, Ziff EB, Llinás R (2000). Synaptophysin regulates clathrin-independent endocytosis of synaptic vesicles. Proc Natl Acad Sci 97: 6120–6125.
Eastwood SL, Harrison PJ (2001). Synaptic pathology in the anterior cingulate cortex in schizophrenia and mood disorders. A review and a western blot study of synaptophysin, GAP-43 and the complexins. Brain Res Bull 55: 569–578.
Egerton A, Brugger S, Raffin M, Barker GJ, Lythgoe DJ, McGuire PK et al (2012). Anterior cingulate glutamate levels related to clinical status following treatment in first-episode schizophrenia. Neuropsychopharmacology 37: 2515–2521.
Fornito A, Yücel M, Dean B, Wood SJ, Pantelis C (2009). Anatomical abnormalities of the anterior cingulate cortex in schizophrenia: bridging the gap between neuroimaging and neuropathology. Schizophr Bull 35: 973–993.
Fremeau RT Jr, Voglmaier S, Seal RP, Edwards RH (2004). VGLUTs define subsets of excitatory neurons and suggest novel roles for glutamate. Trends Neurosci 27: 98–103.
Garrity AG, Pearlson GD, McKiernan K, Lloyd D, Kiehl KA, Calhoun VD (2007). Aberrant ‘default mode’ functional connectivity in schizophrenia. Am J Psychiatry 164: 450–457.
Gemmell HG, Evans NT, Besson JA, Roeda D, Davidson J, Dodd MG et al (1990). Regional cerebral blood flow imaging: a quantitative comparison of technetium-99m-HMPAO SPECT with C15O2 PET. J Nucl Med 10: 1595–1600.
Gerber DJ, Hall D, Miyakawa T, Demars S, Gogos JA, Karayiorgou M et al (2003). Evidence for association of schizophrenia with genetic variation in the 8p21.3 gene, PPP3CC, encoding the calcineurin gamma subunit. Proc Natl Acad Sci USA 100: 8993–8998.
Greicius MD, Krasnow B, Reiss AL, Menon V (2003). Functional connectivity in the resting brain: a network analysis of the default mode hypothesis. Proc Natl Acad Sci USA 100: 253–258.
Greengard P (2001). The neurobiology of dopamine signaling. Biosci Rep 21: 247–269.
Kane JM, Honigfeld G, Singer J, Meltzer H (1988). Clozapine in treatment-resistant schizophrenics. Psychopharmacol Bull 24: 62–67.
Kegeles LS, Abi-Dargham A, Frankle WG, Gil R, Cooper TB, Slifstein M et al (2010). Increased synaptic dopamine function in associative regions of the striatum in schizophrenia. Arch Gen Psychiatry 67: 231–239.
Kozlovsky N, Scarr E, Dean B, Agam G (2006). Postmortem brain calcineurin protein levels in schizophrenia patients are not different from controls. Schizophr Res 83: 173–177.
Kraguljac NV, Reid MA, White D, Jones R, den Hollander J, Lowman D et al (2012a). Neurometabolites in schizophrenia and bipolar disorder – a systematic review and metaanalysis. Psychiatry Res 203: 111–125.
Kraguljac NV, Reid MA, White DM, den Hollander J, Lahti AC (2012b). Regional decoupling of N-acetyl-aspartate and glutamate in schizophrenia. Neuropsychopharmacology 37: 2635–2642.
Kwon SE, Chapman ER (2011). Synaptophysin regulates the kinetics of synaptic vesicle endocytosis in central neurons. Neuron 70: 847–854.
Lahti AC, Weiler MA, Holcomb HH, Tamminga CA, Carpenter WT, McMahon R (2006). Correlations between rCBF and symptoms in two independent cohorts of drug-free patients with schizophrenia. Neuropsychopharmacology 31: 221–230.
Lahti AC, Weiler MA, Holcomb HH, Tamminga CA, Cropsey KL (2009). Modulation of limbic circuitry predicts treatment response to antipsychotic medication: a functional imaging study in schizophrenia. Neuropsychopharmacology 34: 2675–2690.
Legros F, Lombès A, Frachon P, Rojo M (2002). Mitochondrial fusion in human cells is efficient, requires the inner membrane potential, and is mediated by mitofusins. Mol Biol Cell 12: 4343–4354.
Lidow MS, Song ZM, Castner SA, Allen PB, Greengard P, Goldman-Rakic PS (2001). Antipsychotic treatment induces alterations in dendrite- and spine-associated proteins in dopamine-rich areas of the primate cerebral cortex. Biol Psychiatry 49: 1–12.
Manji H, Kato T, Di Prospero NA, Ness S, Beal MF, Krams M et al (2012). Impaired mitochondrial function in psychiatric disorders. Nat Rev Neurosci 13: 293–307.
McMahon HT, Bolshakov VY, Janz R, Hammer RE, Siegelbaum SA, Südhof TC (1996). Synaptophysin, a major synaptic vesicle protein, is not essential for neurotransmitter release. Proc Natl Acad Sci USA 93: 4760–4764.
Meltzer HY (1997). Treatment-resistant schizophrenia–the role of clozapine. Curr Med Res Opin 14: 1–20 Review.
Misko A, Jiang S, Wegorzewska I, Milbrandt J, Baloh RH (2010). Mitofusin 2 is necessary for transport of axonal mitochondria and interacts with the Miro/Milton complex. J Neurosci 30: 4232–4240.
Oni-Orisan A, Kristiansen LV, Haroutunian V, Meador-Woodruff JH, McCullumsmith RE (2008). Altered vesicular glutamate transporter expression in the anterior cingulate cortex in schizophrenia. Biol Psychiatry 63: 766–775.
Perez-Costas E, Melendez-Ferro M, Rice MW, Conley RR, Roberts RC (2012). Dopamine pathology in schizophrenia: analysis of total and phosphorylated tyrosine hydroxylase in the substantia nigra. Front Psychiatry 3: 31.
Reid MA, Stoeckel LE, White DM, Avsar KB, Bolding MS, Akella NS et al (2010). Assessments of function and biochemistry of the anterior cingulate cortex in schizophrenia. Biol Psychiatry 68: 625–633.
Roberts R, Roche J, Somerville S, Conley R (2012). Ultrastructural distinctions between treatment responders and non-responders in schizophrenia: postmortem studies of the striatum. In: L'Abate L (eds) Mental Illness/Book 2. InTech: Rijeka, Croatia. pp 261–286.
RodrÃguez VM, Andrée RM, Castejón MJ, Zamora ML, Alvaro PC, Delgado JL et al (1997). Fronto-striato-thalamic perfusion and clozapine response in treatment-refractory schizophrenic patients. A 99mTc-HMPAO study. Psychiatry Res 76: 51–61.
Rushlow WJ, Seah YH, Belliveau DJ, Rajakumar N (2005). Changes in calcineurin expression induced in the rat brain by the administration of antipsychotics. J Neurochem 4: 587–596.
Selemon LD, Goldman-Rakic PS (1999). The reduced neuropil hypothesis: a circuit based model of schizophrenia. Biol Psychiatry 45: 17–25.
Sheitman BB, Lieberman JA (1998). The natural history and pathophysiology of treatment resistant schizophrenia. J Psychiatr Res 32: 143–150.
Sheng ZH, Cai Q (2012). Mitochondrial transport in neurons: impact on synaptic homeostasis and neurodegeneration. Nat Rev Neurosci 13: 77–93.
Staal WG, Hulshoff Pol HE, Schnack HG, van Haren NE, Seifert N, Kahn RS (2001). Structural brain abnormalities in chronic schizophrenia at the extremes of the outcome spectrum. Am J Psychiatry 158: 1140–1142.
Sun T, Wu XS, Xu J, McNeil BD, Pang ZP, Yang W et al (2010). The role of calcium/calmodulin-activated calcineurin in rapid and slow endocytosis at central synapses. J Neurosci 30: 11838–11847.
Theberge J, Al-Semaan Y, Williamson PC, Menon RS, Neufeld RW, Rajakumar N et al (2003). Glutamate and glutamine in the anterior cingulate and thalamus of medicated patients with chronic schizophrenia and healthy comparison subjects measured with 4.0-T proton MRS. Am J Psychiatry 160: 2231–2233.
Todtenkopf MS, Vincent SL, Benes FM (2005). A cross-study meta-analysis and three-dimensional comparison of cell counting in the anterior cingulate cortex of schizophrenic and bipolar brain. Schizophr Res 73: 79–89.
Wada A, Kunii Y, Ikemoto K, Yang Q, Hino M, Matsumoto J et al (2012). Increased ratio of calcineurin immunoreactive neurons in the caudate nucleus of patients with schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 37: 8–14.
Wiedenmann B, Franke WW (1985). Identification and localization of synaptophysin, an integral membrane glycoprotein of Mr 38 000 characteristic of presynaptic vesicles. Cell 41: 1017–1028.
Wilson NR, Kang J, Hueske EV, Leung T, Varoqui H, Murnick JG et al (2005). Presynaptic regulation of quantal size by the vesicular glutamate transporter VGLUT1. J Neurosci 25: 6221–6234.
Wojcik SM, Rhee JS, Herzog E, Sigler A, Jahn R, Takamori S et al (2004). An essential role for vesicular glutamate transporter 1 (VGLUT1) in postnatal development and control of quantal size. Proc Natl Acad Sci USA 101: 7158–7163.
Yamada K, Gerber DJ, Iwayama Y, Ohnishi T, Ohba H, Toyota T et al (2007). Genetic analysis of the calcineurin pathway identifies members of the EGR gene family, specifically EGR3, as potential susceptibility candidates in schizophrenia. Proc Natl Acad Sci USA 104: 2815–2820.
Acknowledgements
We thank the Maryland Brain Collection for the brain samples (especially Dr Robert Conley, diagnoses, and Dr Andree Lessard, dissections), and Dr Miguel Melendez-Ferro and Dr Emma Perez-Costas for technical expertise with the western blots.
Author information
Authors and Affiliations
Corresponding author
Additional information
Supplementary Information accompanies the paper on the Neuropsychopharmacology website
Supplementary information
Rights and permissions
About this article
Cite this article
Barksdale, K., Lahti, A. & Roberts, R. Synaptic Proteins in the Postmortem Anterior Cingulate Cortex in Schizophrenia: Relationship to Treatment and Treatment Response. Neuropsychopharmacol 39, 2095–2103 (2014). https://doi.org/10.1038/npp.2014.57
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/npp.2014.57
This article is cited by
-
Synaptic loss in schizophrenia: a meta-analysis and systematic review of synaptic protein and mRNA measures
Molecular Psychiatry (2019)
